Quest PharmaTech (CVE:QPT) Stock Price Up 33.3% – Time to Buy?

Quest PharmaTech Inc. (CVE:QPT) shot up 33.3% during mid-day trading on Thursday . The company traded as high as C$0.04 and last traded at C$0.04. 248,000 shares changed hands during trading, an increase of 429% from the average session volume of 46,868 shares. The stock had previously closed at C$0.03.

Quest PharmaTech Stock Up 33.3%

The company has a market cap of C$6.77 million, a P/E ratio of -40.00 and a beta of -0.23. The company has a debt-to-equity ratio of 4.35, a current ratio of 0.40 and a quick ratio of 0.52. The company’s 50-day moving average is C$0.03 and its two-hundred day moving average is C$0.04.

Quest PharmaTech Company Profile

Quest PharmaTech Inc, a pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer. Its lead product candidate is Mab AR 9.6 against truncated O-glycan on MUC16, for targeted cancer therapy applications. The company also offers Oregovomab, which is in Phase III clinical trial for the treatment of ovarian cancer. In addition, it develops, manufactures, and commercializes immunotherapy products for pancreatic cancer; and combinatorial immunotherapeutic products for the treatment cancer by using monoclonal antibodies of the immunoglobulin of G and E class.